摘要:
The invention is based on the discovery that certain well-defined compounds derived from pentacyclopentadecane dimethanol are useful components in adhesive formulations. In particular, the invention compounds described herein provide high Tg values and low shrinkage. Compounds of the invention are useful as adhesives for use in the semiconductor packaging industry.
摘要:
The present invention relates to an oxetane compound containing a (meth)acryloyl group represented by formula (1) having a high copolymerizability with compounds containing a (meth)acryloyl group, and to a production method of an oxetane compound containing a (meth)acryloyl group which is characterized by reacting an isocyanate compound having a (meth)acryloyl group represented by formula (5) with an oxetane compound containing a hydroxyl group represented by formula (6). (In the formula, R1 represents a hydrogen atom or a methyl group, A represents —OR2— or a bond, R2 represents a divalent hydrocarbon group which may contain an oxygen atom in the main chain, R3 represents a linear or branched alkylene group having 1 to 6 carbon atoms, and R4 represents a linear or branched alkyl group having 1 to 6 carbon atoms.)
摘要:
The present invention provides a chemiluminescence enhancer treated to retain favorable dispersibility of fine solid carriers and stably exert a chemiluminescence enhancing action. The invention provides a chemiluminescence enhancer used for signal detection in a solid phase immunoassay using antigen or/and antibody immobilized onto fine solid carriers dispersible in a liquid medium, consisting of a water soluble macromolecular quaternary ammonium salt, a quaternary sulfonium salt or a quaternary phosphonium salt in order to enhance emission of light caused by an enzymatic reaction of a chemiluminescent substrate having dioxetane, wherein the chemiluminescence enhancer is given an aggregation inhibition treatment of the fine solid carriers by the treatment with an oxidizing agent or a reducing agent, and a chemiluminescence method and a kit using the chemiluminescence enhancer.
摘要:
HIV protease inhibitors inhibit or block the biological activity of the HIV protease enzyme, causing the replication of the HIV virus to terminate. These compounds can be prepared by the novel methods of the present invention using the novel inventive intermediates.
摘要:
Disclosed are coated metal oxide nanoparticles comprising a metal oxide nanoparticle having a surface; and ligands attached to the metal oxide nanoparticle surface. Also disclosed are phosphonic acid compounds comprising the structure Gn-R-Xn, wherein G is a terminal group; wherein R is a bridging group; wherein X is a phosphonic acid group; and wherein each n is, independently, 1, 2, or 3. Also disclosed are methods for preparing and using coated metal oxide nanoparticles. Also disclosed are nanocomposite compositions comprising a polymer; and a coated metal oxide nanoparticle dispersed within the polymer. Also disclosed are articles, films, and capacitors comprising a coated metal oxide nanoparticle or a nanocomposite composition. This abstract is intended as a scanning tool for purposes of searching in the particular art and is not intended to be limiting of the present invention.
摘要:
Disclosed is a process for purifying a hydroxycarboxylic acid, comprising: a crystallization step of subjecting a hydroxycarboxylic acid aqueous solution to crystallization for purification, a separation step of separating a hydroxycarboxylic acid crystal from a mother liquid, and a washing step of washing the hydroxycarboxylic acid crystal for further purification with a washing liquid, wherein the washing liquid is a hydroxycarboxylic acid aqueous solution. The purified or refined hydroxycarboxylic acid obtained through the above process is suitably used as a starting material for production of a polyhydroxycarboxylic acid. The above process is suitably included in a process for producing a cyclic ester and a process for producing a polyhydroxycarboxylic acid.
摘要:
The present invention provides a heat-generating agent or singlet oxygen-generating agent effective as a new cancer treatment agent which, unlike an anticancer agent based on an alkylating agent such as MMC, uses the action of heat and/or singlet oxygen to kill cancer cells and reduce the burden on patients. A heat- and/or singlet oxygen-generating agent or a cancer treatment agent, comprising an organic peroxide such as the peroxide of an imidazole derivative or a chemiluminescent compound such as a dioxetane compound.
摘要:
The present invention discloses a curable polycyclic compound represented by the following formula (1): {wherein A is a di- to hexa-valent group derived from a polycyclic hydrocarbon compound; R1 is an alkyl group of 1 to 4 carbon atoms, a perfluoroalkyl group of 1 to 4 carbon atoms, or a fluorine atom; n is an integer of 0 to 2; m is an integer of 2 to 4; and Y is a group represented by the following formula (2) or (3): (wherein R2, R3, R5 and R6 are each independently a hydrogen atom, a fluorine atom or an alkyl group of 1 to 4 carbon atoms; R4 is a methyl group or an ethyl group; and p and q are each independently an integer of 0 to 4)}.
摘要翻译:本发明公开了由下式(1)表示的可固化多环化合物:其中A是衍生自多环烃化合物的二价至六价基团; R 1是1至4个碳原子的烷基,1至4个碳原子的全氟烷基或氟原子; n为0〜2的整数, m为2〜4的整数, 并且Y是由下式(2)或(3)表示的基团:其中R 2,R 3,R 5和 R 6各自独立地是氢原子,氟原子或1-4个碳原子的烷基; R 4是甲基或乙基; p 和q各自独立地为0〜4的整数)}。
摘要:
The present invention provides an oxetane compound represented by the following formula (1), and a active energy ray-curable composition including the oxetane compound as a polymerizable monomer. In formula (1), R11 to R15 each independently represents a hydrogen atom or an alkyl group; R21 to R24 each independently represents a hydrogen atom, an alkyl group, an alkoxy group or a halogen atom; R represents an alkyl group including a partial structure selected from an oxirane ring, an oxetane ring or a vinyl ether and having from 3 to 10 carbon atoms, or a vinyl group; and any adjacent groups among R21 to R24 and R may be bonded to each other to form a ring structure